New Law Expands Tick-Borne Disease Research
The act boosts funding for research, testing, and treatment of tick-borne illnesses across the United States.
Updated on Oct. 5, 2026 in COVID-19
Live Poll
Should the federal government increase funding for tracking and treating tick-borne illnesses?
The President has signed the Kay Hagan Tick Reauthorization Act into law, expanding federal support for the study and treatment of tick-borne diseases. This legislation arrives as the country works to address rising rates of illnesses like Lyme disease.
Why it matters
The new law aims to strengthen public health infrastructure by supporting improved testing and treatment options for patients. This effort directly addresses the rising prevalence of tick-borne infections across the United States.
Official state surveillance data from 2024 shows Minnesota recorded 3,551 cases of Lyme disease, alongside hundreds of other tick-borne infections. The efficacy of the newly reauthorized programs in reducing these case counts is still under investigation.
The players
Kay Hagan
Late U.S. Senator who died following complications from the Powassan virus.
Centers for Disease Control and Prevention
Federal agency responsible for protecting public health through the control and prevention of infectious diseases.
Department of Health and Human Services
Cabinet-level executive department responsible for federal health policy and the National Public Health Strategy for Vector-Borne Diseases.
The details
The law authorizes the continuation of the Department of Health and Human Services' National Public Health Strategy for Vector-Borne Diseases for five years. By reauthorizing Regional Centers of Excellence and providing CDC grants to state health departments, the act facilitates a coordinated national approach to managing tick habitats and pathogen monitoring. This infrastructure allows researchers to better investigate the biological mechanisms of these pathogens and improve clinical diagnostic accuracy for patients.
Timeline
October 28, 2019: Senator Kay Hagan died from complications of the Powassan virus.
2024: Minnesota recorded 3,551 cases of Lyme disease.
August 2026: The U.S. Senate passed the bill.
Mid-September 2026: The U.S. House of Representatives passed the bill.
October 5, 2026: The President signed the act into law.
Health Landscape
This law supports the ongoing implementation of the National Public Health Strategy for Vector-Borne Diseases. It marks a formal commitment to sustain the institutional research networks established to counter rising rates of tick-borne pathogens.
Residents in areas with high tick activity should remain vigilant about prevention and early symptom recognition. If you live in an endemic area or have recently spent time outdoors, discuss any unexplained fever or rash with your physician.
The takeaway
This act prioritizes long-term investment in the research and diagnostic infrastructure needed to combat tick-borne illnesses. To protect your health, continue using proven preventive measures like tick checks and protective clothing when spending time in wooded or grassy areas.
Further reading
For broader context on how federal public health initiatives monitor and respond to infectious disease threats, visit the COVID-19 section.
Source note: This article includes information reported by Gold Rush Cam.
Live Poll
Should the federal government increase funding for tracking and treating tick-borne illnesses?
